초록 ▼

Genetic testing allows an individual to determine whether or not he or she has a predisposition to a certain disease. The degree of expressivity of a certain disease will be determined in part by an individual's environment and lifestyle. The present invention interprets a patient's gene sequence an

Genetic testing allows an individual to determine whether or not he or she has a predisposition to a certain disease. The degree of expressivity of a certain disease will be determined in part by an individual's environment and lifestyle. The present invention interprets a patient's gene sequence and his or her environment and lifestyle to come up with a personalized prognosis. This procedure can be repeated many times over the course of a disease state to monitor a patient's condition. In addition, disease-causing pathogens can also have their genes sequenced. Using these sequences in combination with information about a patient's environment and lifestyle, it is possible to come up with a personalized treatment plan, ideally to eliminate the pathogen. It is also possible to use the procedure described above to monitor the course of the disease-state produced by a pathogen. Finally, a genotype-to-phenotype map or database can be constructed for developing better treatments and for research purposes.

대표청구항 ▼

[ What is claimed is:] [1.] A system for developing a personalized treatment, the system comprising:a) a means for sequencing a gene and for providing at least one patient-specific gene sequence;b) a database of known gene sequences and associated scripts assigned to said known gene sequences; andc)

[ What is claimed is:] [1.] A system for developing a personalized treatment, the system comprising:a) a means for sequencing a gene and for providing at least one patient-specific gene sequence;b) a database of known gene sequences and associated scripts assigned to said known gene sequences; andc) a health monitor for interpreting said at least one patient-specific gene sequence, for receiving said associated scripts from said database, for presenting said associated scripts to a patient and for determining a degree of expressivity of a phenotype associated with a genotype based on a response of the patient to said associated scripts.